Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins

This review examines the development of endothelial dysfunction in chronic venous diseases  (СVD), the multifactority of this process. The important role of the nitric oxide system as a universal modulator of various biochemical reactions and realization of many important physiological  functions is...

Full description

Bibliographic Details
Main Authors: A. V. Voronkov, O. Yu. Gamzeleva
Format: Article
Language:Russian
Published: Remedium Group LTD 2019-04-01
Series:Амбулаторная хирургия
Subjects:
Online Access:https://www.a-surgeon.ru/jour/article/view/133
_version_ 1797883979694604288
author A. V. Voronkov
O. Yu. Gamzeleva
author_facet A. V. Voronkov
O. Yu. Gamzeleva
author_sort A. V. Voronkov
collection DOAJ
description This review examines the development of endothelial dysfunction in chronic venous diseases  (СVD), the multifactority of this process. The important role of the nitric oxide system as a universal modulator of various biochemical reactions and realization of many important physiological  functions is shown. The need for early pharmacotherapy of phleboprotectors with endothelioprotective activity is discussed  in order to slow the progression  of CVD. Effects of flavonoids as perspective endothelioprotectors on various links in the pathogenesis of endothelial dysfunction are considered. On the example of the micronized purified  flavonoid fraction (MPFF), the effect of flavonoid compounds on endothelial dysfunction in CVD is demonstrated, and the mechanisms of action have been examined in detail. In addition, the pharmacological  effects  of individual components of the MPFF and their synergism in the focus on the effect on endothelial dysfunction are also discussed.  Features  of the micronized form that affect bioavailability and, ultimately, determine the pharmacological  effectiveness of the drug are considered.
first_indexed 2024-04-10T04:00:20Z
format Article
id doaj.art-3bbdb8015f294175acb43adece655361
institution Directory Open Access Journal
issn 2712-8741
2782-2591
language Russian
last_indexed 2024-04-10T04:00:20Z
publishDate 2019-04-01
publisher Remedium Group LTD
record_format Article
series Амбулаторная хирургия
spelling doaj.art-3bbdb8015f294175acb43adece6553612023-03-13T07:10:18ZrusRemedium Group LTDАмбулаторная хирургия2712-87412782-25912019-04-0101-2273310.21518/1995-1477-2019-1-2-27-33130Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veinsA. V. Voronkov0O. Yu. Gamzeleva1Пятигорский медико-фармацевтический институт – филиал государственного бюджетного образовательного учреждения высшего профессионального образования «Волгоградский государственный медицинский университет» Министерства здравоохранения Российской Федерации»Пятигорский медико-фармацевтический институт – филиал государственного бюджетного образовательного учреждения высшего профессионального образования «Волгоградский государственный медицинский университет» Министерства здравоохранения Российской Федерации»This review examines the development of endothelial dysfunction in chronic venous diseases  (СVD), the multifactority of this process. The important role of the nitric oxide system as a universal modulator of various biochemical reactions and realization of many important physiological  functions is shown. The need for early pharmacotherapy of phleboprotectors with endothelioprotective activity is discussed  in order to slow the progression  of CVD. Effects of flavonoids as perspective endothelioprotectors on various links in the pathogenesis of endothelial dysfunction are considered. On the example of the micronized purified  flavonoid fraction (MPFF), the effect of flavonoid compounds on endothelial dysfunction in CVD is demonstrated, and the mechanisms of action have been examined in detail. In addition, the pharmacological  effects  of individual components of the MPFF and their synergism in the focus on the effect on endothelial dysfunction are also discussed.  Features  of the micronized form that affect bioavailability and, ultimately, determine the pharmacological  effectiveness of the drug are considered.https://www.a-surgeon.ru/jour/article/view/133оксид азотаэндотелийхронические заболевания венфлебопротекторфлавоноидымоффдетралекс
spellingShingle A. V. Voronkov
O. Yu. Gamzeleva
Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins
Амбулаторная хирургия
оксид азота
эндотелий
хронические заболевания вен
флебопротектор
флавоноиды
мофф
детралекс
title Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins
title_full Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins
title_fullStr Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins
title_full_unstemmed Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins
title_short Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins
title_sort review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins
topic оксид азота
эндотелий
хронические заболевания вен
флебопротектор
флавоноиды
мофф
детралекс
url https://www.a-surgeon.ru/jour/article/view/133
work_keys_str_mv AT avvoronkov reviewofmodernphlebotrophicpreparationsbasedonflavonoidsasperspectiveendothelioprotectorsinthetreatmentofchronicdiseasesoftheveins
AT oyugamzeleva reviewofmodernphlebotrophicpreparationsbasedonflavonoidsasperspectiveendothelioprotectorsinthetreatmentofchronicdiseasesoftheveins